How much funding has Berentx raised?

Berentx has raised $135.0M in total funding, most recently a Series A round.

Where is Berentx headquartered?

Berentx is headquartered in Thousand Oaks, California, United States.

What industry is Berentx in?

Berentx operates in Biotech, Healthcare.

Berentx

Q: Who are Berentx's investors?

Berentx's investors include Wellington Management, JIC Ventures Growth Investments, Founders Fund, Narya, Eisai.

Building with purpose and taking our responsibility seriously

Thousand Oaks, United States · Founded 2020 · $135.0M raised

Biotech

Healthcare

Headquarters: Thousand Oaks, California
Employees: 51–200
Founded: 2020
Business Model: B2B

Website: berentx.com
Total Funding: $135.0M
Last Round: $135.0M Series AAug 2021
Rounds: 2

About

Beren Therapeutics P.B.C. (traded as Berentx) is a fully integrated, clinical-stage biotechnology public benefit corporation headquartered in Thousand Oaks, California, with additional locations in South San Francisco, Boston, Budapest, Tokyo, and New Jersey. Founded in 2020 by Jason Camm, the company focuses on developing cyclodextrin-based therapeutics for conditions characterized by impaired intracellular cholesterol trafficking, including Niemann-Pick disease type C (NPC) and related neurodegenerative conditions. Beren's patient-aligned model integrates drug discovery, clinical development, manufacturing, and commercial expertise, working in close partnership with patient communities and caregivers. The company raised $300 million in 2026 financing and has approximately 103 employees.

Summary

Berentx is a Biotech company based in Thousand Oaks, United States, founded in 2020. It has raised $135.0M in total across 2 rounds, most recently a $135.0M Series A round in Aug 2021. Investors include Wellington Management, JIC Ventures Growth Investments and Founders Fund.